全文获取类型
收费全文 | 4748篇 |
免费 | 452篇 |
国内免费 | 45篇 |
专业分类
耳鼻咽喉 | 40篇 |
儿科学 | 235篇 |
妇产科学 | 68篇 |
基础医学 | 530篇 |
口腔科学 | 52篇 |
临床医学 | 538篇 |
内科学 | 1374篇 |
皮肤病学 | 104篇 |
神经病学 | 352篇 |
特种医学 | 393篇 |
外国民族医学 | 3篇 |
外科学 | 644篇 |
综合类 | 36篇 |
预防医学 | 279篇 |
眼科学 | 115篇 |
药学 | 220篇 |
中国医学 | 1篇 |
肿瘤学 | 261篇 |
出版年
2023年 | 70篇 |
2022年 | 27篇 |
2021年 | 83篇 |
2020年 | 117篇 |
2019年 | 67篇 |
2018年 | 152篇 |
2017年 | 103篇 |
2016年 | 114篇 |
2015年 | 112篇 |
2014年 | 164篇 |
2013年 | 210篇 |
2012年 | 178篇 |
2011年 | 207篇 |
2010年 | 155篇 |
2009年 | 177篇 |
2008年 | 170篇 |
2007年 | 166篇 |
2006年 | 189篇 |
2005年 | 159篇 |
2004年 | 127篇 |
2003年 | 125篇 |
2002年 | 134篇 |
2001年 | 141篇 |
2000年 | 136篇 |
1999年 | 143篇 |
1998年 | 116篇 |
1997年 | 140篇 |
1996年 | 103篇 |
1995年 | 97篇 |
1994年 | 69篇 |
1993年 | 77篇 |
1992年 | 107篇 |
1991年 | 94篇 |
1990年 | 83篇 |
1989年 | 128篇 |
1988年 | 92篇 |
1987年 | 75篇 |
1986年 | 62篇 |
1985年 | 57篇 |
1984年 | 46篇 |
1983年 | 36篇 |
1982年 | 26篇 |
1981年 | 35篇 |
1980年 | 27篇 |
1979年 | 38篇 |
1978年 | 30篇 |
1977年 | 27篇 |
1976年 | 26篇 |
1973年 | 25篇 |
1971年 | 23篇 |
排序方式: 共有5245条查询结果,搜索用时 15 毫秒
1.
2.
3.
4.
5.
6.
7.
Robotic-assisted heller myotomy versus laparoscopic heller myotomy for the treatment of esophageal achalasia: multicenter study 总被引:3,自引:0,他引:3
Santiago Horgan M.D. Carlos Galvani M.D. Maria V. Gorodner M.D. Pablo Omelanczuck M.D. Fernando Elli M.D. Federico Moser M.D. Luis Durand M.D. Miguel Caracoche M.D. Jorge Nefa M.D. Sergio Bustos M.D. Phillip Donahue M.D. Pedro Ferraina M.D. 《Journal of gastrointestinal surgery》2005,9(8):1020-1030
Laparoscopic Heller myotomy (LHM) has become the standard treatment option for achalasia. The incidence of esophageal perforation
reported is about 5%–10%. Robotically assisted Heller myotomy (RAHM) is emerging as a safe alternative to LHM. Data comparing
the two approaches are scant. The aim of this study was to compare RAHM with LHM in terms of efficacy and safety for treatment
of achalasia. A total of 121 patients underwent surgical treatment of achalasia at three institutions. A retrospective review
of prospectively collected perioperative data was performed. Patients were divided into two groups: group A (RAHM), 59 patients,
and group B (LHM), 62 patients. All the operations were completed using minimally invasive techniques. There were 63 women
and 58 men, with a mean age of 45 ±19 years (14–82 years). Fifty-one percent of patients in group A and 95% of patients in
group B reported weight loss. Duration of symptoms was equal for both groups. Dysphagia was the main complaint in both groups
(P = NS). There was no difference in preoperative endoscopic treatment in both groups (44% versus 27%, P = NS). Operative
time was significantly shorter for LHM in the first half of the experience (141 ± 49 versus 122 ± 44 minutes, P < .05). However,
in the last 30 cases there was no difference in operative time between the groups (P = NS). Intraoperative complications (esophageal
perforation) were more frequent in group B (16% versus 0%). The incidence of postoperative heartburn did not differ by group.
There were no deaths. At 18 and 22 months, 92% and 90% of patients had relief of their dysphagia. This study suggests that
RAHM is safer than LHM, because it decreases the incidence of esophageal perforation to 0%, even in patients who had previous
treatment. At short-term follow-up, relief of dysphagia was equally achieved in both groups.
Presented at the Forty-Sixth Annual Meeting of The Society for Surgery of the Alimentary Tract, Chicago, Illinois, May 14–18,
2005 (oral presentation).
This study was supported in part by a grant provided by Intuitive Surgical, Inc. and Ethicon Endo-Surgery, Inc. 相似文献
8.
We report the occurrence of an acute encephalopathy followingifosfamide infusion, that we believe directly triggered by aprepitant(EmendTM, Merck & Co., Inc.). Aprepitant, the first neurokinin-1receptor antagonist, is a new antiemetic indicated for highlyand moderately emetogenic chemotherapy, in association with 相似文献
9.
10.
B. Lacarelle O. Blin C. Audebert P. Auquier H. Karsenty F. Horriere A. Durand 《European journal of clinical pharmacology》1994,46(5):477-478
The kinetics of a single i. v. dose of theophylline given either alone or with flumequine was studied in eight healthy volunteers. No statistically significant differences were observed in the pharmacokinetic parameters of theophylline (volume of distribution, elimination half-life, AUC, plasma clearance) following the two treatments.Pretreatment for 5 days with oral flumequine (400 mg, three times daily) had no significant effect on the disposition of a single i. v. dose of theophylline in healthy volunteers. 相似文献